These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7037272)

  • 1. [Side effects of benzodiazepines: "rebound" anxiety and insomnia].
    Pesce A; Rossi F; Valeri P
    Clin Ter; 1981 Dec; 99(5):461-70. PubMed ID: 7037272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does a rebound insomnia following benzodiazepine administration exist?].
    Ladewig D
    Dtsch Med Wochenschr; 1980 Oct; 105(43):1483-4. PubMed ID: 7428651
    [No Abstract]   [Full Text] [Related]  

  • 3. Benzodiazepine hypnotics: carryover effectiveness, rebound insomnia, and performance effects.
    Kales A
    NIDA Res Monogr; 1980; (33):61-9. PubMed ID: 6119616
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam withdrawal insomnia.
    Slak S
    Psychol Rep; 1986 Apr; 58(2):343-6. PubMed ID: 2871575
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacology and therapeutics of benzodiazepines.
    Zarowny DP
    Can Med Assoc J; 1979 Dec; 121(12):1571. PubMed ID: 534972
    [No Abstract]   [Full Text] [Related]  

  • 7. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of patients with benzodiazepine dependence, hospitalised between 2006-2008].
    Străulea AO; Chiriţă V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):89-92. PubMed ID: 21495303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early morning insomnia, daytime anxiety, and organic mental disorder associated with triazolam.
    Tan TL; Bixler EO; Kales A; Cadieux RJ; Goodman AL
    J Fam Pract; 1985 Jun; 20(6):592-4. PubMed ID: 2860198
    [No Abstract]   [Full Text] [Related]  

  • 10. Benzodiazepine dependence.
    Khong E; Sim MG; Hulse G
    Aust Fam Physician; 2004 Nov; 33(11):923-6. PubMed ID: 15584332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.
    Kales A; Scharf MB; Kales JD; Soldatos CR
    JAMA; 1979 Apr; 241(16):1692-5. PubMed ID: 430730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of benzodiazepines.
    Med Lett Drugs Ther; 1988 Feb; 30(760):26-8. PubMed ID: 2893246
    [No Abstract]   [Full Text] [Related]  

  • 13. [Benzodiazepine--practice and problems of its use].
    Meier PJ; Ziegler WH; Neftel K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):381-92. PubMed ID: 3287602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine withdrawal and rebound insomnia.
    Morgan K; Tomeny M
    Acta Psychiatr Scand; 1989 Sep; 80(3):297-8. PubMed ID: 2573235
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
    Soldatos CR; Dikeos DG; Whitehead A
    Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebound insomnia and rebound anxiety: a review.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound insomnia: its determinants and significance.
    Roehrs T; Vogel G; Roth T
    Am J Med; 1990 Mar; 88(3A):39S-42S. PubMed ID: 1968719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and management of benzodiazepine dependence.
    Tyrer PJ; Seivewright N
    Postgrad Med J; 1984; 60 Suppl 2():41-6. PubMed ID: 6146970
    [No Abstract]   [Full Text] [Related]  

  • 19. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
    Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
    Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological distress and adaptational problems associated with benzodiazepine withdrawal and outcome: a replication.
    O'Connor KP; Marchand A; Bélanger L; Mainguy N; Landry P; Savard P; Turcotte J; Dupuis G; Harel F; Lachance L
    Addict Behav; 2004 May; 29(3):583-93. PubMed ID: 15050676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.